“…In the present investigation, a total of 738 DEGs between COVID-19 samples and non COVID-19 samples were identified, consisting of 415 [76], SIGLEC1 [77] and IL1R2 [78] have been suggested to be associated with neurological diseases. CXCL9 [79], SIGLEC1 [80], IL1R2 [81], KLF15 [82] and CD207 [83] [146], STAT4 [147], CXCL8 [148], KLF2 [149], ADM (adrenomedullin) [150], EGR1 [151], TRIB1 [152], SOD2 [153] [162], PTEN (phosphatase and tensin homolog) [163], FOXO3 [164], DDIT4 [165], PINK1 [166], IQGAP1 [167], ADIPOR1 [168], MTMR3 [169] [464], IFNG (interferon gamma) [465], IFIH1 [466], STAT1 [467], CCR5 [468], ADCY5 [469], MT2A [470], DPP4 [471], FASLG (Fas ligand) [472], HLA-DMB [473], CD3D [474], CMKLR1 [475], ICOS (inducible T cell costimulator) [476] [492], CFB (complement factor B) [493], TLR7 [494], SLAMF1 [495], BPIFA1 [496], CD300E [497], TAP2 [498], CD48 [499], APOL1 [500], BACH2 [501], CD226 [502], CXCL12…”